LYFT Inc diskutieren
LYFT Inc
WKN: A2PE38 / Symbol: LYFT / Name: LYFT / Aktie / Software & Informationsdienstleistungen / Large Cap /
15,10 €
6,01 %
Lyft (LYFT) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) had its "buy" rating reaffirmed by Guggenheim.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) was upgraded by Rothschild & Co Redburn from "neutral" to "buy". They now have a $22.00 price target on the stock.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) was upgraded by Morgan Stanley from "equal weight" to "overweight".
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) is now covered by Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) was upgraded by BTIG Research from "neutral" to "buy".
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) is now covered by Sanford C. Bernstein. They set an "underperform" rating on the stock.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) had its "buy" rating reaffirmed by Tigress Financial. They now have a $28.00 price target on the stock.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $21.00 price target on the stock, up from $20.00.
Ratings data for LYFT provided by MarketBeat
Lyft (LYFT) had its price target raised by Royal Bank Of Canada from $18.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for LYFT provided by MarketBeat
Neueste Beiträge
TD_Cowen in Halozyme Therapeutics Inc. diskutieren